Cancer Drug Developer Finds Potent Hits With AI in British Columbia
Source: Streetwise Reports (07/25/2025)
Rakovina Therapeutics Inc. (RKV:TSX.V) taps machine learning to zero in on novel cancer therapies. Read more about the AI engine driving this high-stakes discovery.
read more >
Pancreas Cancer Becoming Top Focus for Biotech Co.?
(07/22/2025)
Oncolytics Biotech Inc. (ONCY:NASDAQ; ONC:TSX) published survival data for the use of its immunotherapy pelareorep in pancreatic cancer, and these support the view that this indication should be primary, noted a Leede Financial Inc. report.
read more >
Biotech Firm Clears Major U.S. Trading Hurdle
Source: Streetwise Reports (07/18/2025)
Rakovina Therapeutics Inc. (RKV:TSX.V) just gained DTC eligibility, opening the door for faster U.S. trades and broader investor access. With AI-driven cancer drugs in development, analysts are taking notice. Read more to find out why.
read more >
Biotech Partnership to Revolutionize Diabetes Treatment
Source: Streetwise Reports (07/15/2025)
Sernova Biotherapeutics Inc. (SVA:TSX.V; SEOVF:OTCQB; PSH:XETRA) announces a collaborative research agreement with Eledon Pharmaceuticals Inc. to assess Eledon's immunosuppressive drug in Sernova's ongoing trials of its cell pouch biohybrid organ for patients with Type 1 diabetes (T1D).
read more >
AI Healthtech Firm Partners with EngageWell and CVS Health Foundation on NYC Senior Care Initiative
Source: Streetwise Reports (07/14/2025)
Treatment.com AI Inc. (TRUE:CSE; TREIF:OTCMKTS; 939:FRA) launches virtual screening for older adults in NYC, backed by US$1M from CVS Health Foundation, as it scales AI tools and patient reach. Read more about how this initiative is helping expand access to care and driving growth in virtual health innovation.
read more >